Galileo - Biotech Innovation Fund BC Fonds
67,46
USD
+0,46
USD
+0,69
%
NAV
Werbung
Top Holdings
Chart
Tabelle
| Name | ISIN | Anteil |
|---|---|---|
| Krystal Biotech Inc | US5011471027 | 8,39% |
| Stoke Therapeutics Inc | US86150R1077 | 6,96% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,50% |
| Arcellx Inc | US03940C1009 | 6,39% |
| Arrowhead Pharmaceuticals Inc | US04280A1007 | 5,06% |
| Taysha Gene Therapies Inc Ordinary Shares | US8776191061 | 3,47% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,44% |
| Gilead Sciences Inc | US3755581036 | 3,38% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,32% |
| uniQure NV | NL0010696654 | 3,13% |
| Sonstige | 49,96% |
